Key Dates

Related Announcements

RFA-CA-22-031 - Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional)

RFA-CA-22-032 - Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a public pre-application webinar on September 26, 2022, from 2:00 pm to 5:00 pm EDT.

NCI staff members involved in managing this program will assist potential applicants by explaining the goals and objectives of these initiatives and answering questions from attendees.

Prospective applicants are encouraged to submit their questions or comments to [email protected] in advance of the webinar.

Registration: Potential applicants interested in participating in the webinar should send an email to:

Juan (Miguel) Villanueva ([email protected]) to obtain registration information no later than 5:00 p.m. (EDT) on September 19, 2022.

Please include "NCI Assistance Webinar for RFA-CA-22-031/032” in the subject line of the email.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-22-031 or RFA-CA-22-032.

Inquiries

Please direct all inquiries to:

Jo Ann Rinaudo, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7133
Email: [email protected]

Matthew Young, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5846
Email: [email protected]

Guillermo Marquez, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7035
Email: [email protected]

Sudhir Srivastava, M.P.H., Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7040
Email: [email protected]